Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
NCT Number: NCT03880747
There is no consensus on what type of function-preserving gastrectomy can provide the best patient quality of life (QOL). This study aims to evaluate the incidence of dumping syndrome after vagus nerve-preserving distal gastrectomy (VPNDG).
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Seongnam-si, Gyeonggi-do, 13620, South Korea
The study is designed as a prospective observational phase II study with a follow-up period of 12 months. Patients diagnosed with early gastric cancer in the distal 2/3rd of the stomach who are planned to undergo laparoscopic VPNDG with Roux-en Y gastrojejunostomy will be enrolled. Primary endpoint is incidence of dumping syndrome defined by Sigstad score 7 after a 3-month interval. Other outcomes include operative data, early complication, and patient QOL using the European Organization for Research and Treatment of Cancer C-30 and STO22 modules.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopic distal gastrectomy with the preservation of the celiac and hepatic branch of the vagus nerve.
Time frame: 1 year
Sigstad score of equal or more than 7
Time frame: 3 months, 6 months, 1 year
Quality of life surveys
Time frame: 3 months, 6 months, 1 year
incidence of postoperative complication
Time frame: 1 year
Found in follow-up CT or ultrasound
Time frame: Immediately after operation
Time of operation
Time frame: Immediately after operation
Blood loss during operation
Time frame: Within 1 week
Postoperative day to first flatus
Time frame: Within 1 week
Total hospital stay
Seoul National University Bundang Hospital
Other
Incidence of Dumping Syndrome After Laparoscopic Vagus Nerve-preserving Distal Gastrectomy for Early Gastric Cancer
Acronym: VNP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03013010
Adenocarcinoma, Carcinoma
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06563063
Digestive System Diseases, Digestive System Neoplasms
Seoul, South Korea
View Trial DetailsNCT05714878
Digestive System Diseases, Digestive System Neoplasms
Beijing, China
View Trial DetailsNCT03549494
Digestive System Disease, Digestive System Diseases
Havana, La Habana, Cuba
View Trial Details